THERAFUZE DBF Trademark

Trademark Overview

On Monday, August 27, 2018, a trademark application was filed for THERAFUZE DBF with the United States Patent and Trademark Office. The USPTO has given the THERAFUZE DBF trademark a serial number of 88093638. The federal status of this trademark filing is REGISTERED as of Tuesday, December 1, 2020. This trademark is owned by TheraCell, Inc.. The THERAFUZE DBF trademark is filed in the Pharmaceutical Products category with the following description:

surgical implants, namely, bone implants comprised of processed biological materials
therafuze dbf

General Information

Serial Number88093638
Word MarkTHERAFUZE DBF
Filing DateMonday, August 27, 2018
Status700 - REGISTERED
Status DateTuesday, December 1, 2020
Registration Number6211650
Registration DateTuesday, December 1, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 12, 2019

Trademark Statements

Goods and Servicessurgical implants, namely, bone implants comprised of processed biological materials
Disclaimer with Predetermined Text"DBF"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 6, 2018
Primary Code005
First Use Anywhere DateFriday, October 9, 2020
First Use In Commerce DateFriday, October 9, 2020

Trademark Owner History

Party NameTHERACELL, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressSHERMAN OAKS, CA 91403
Party NameTheraCell, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSherman Oaks, CA 91403
Party NameTheraCell, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSherman Oaks, CA 91403
Party NameTheraCell, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSherman Oaks, CA 91403

Trademark Events

Event DateEvent Description
Wednesday, October 18, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 10, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 10, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 10, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 10, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 1, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, October 27, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, October 26, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, October 24, 2020STATEMENT OF USE PROCESSING COMPLETE
Friday, October 9, 2020USE AMENDMENT FILED
Saturday, October 24, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 9, 2020TEAS STATEMENT OF USE RECEIVED
Saturday, April 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 9, 2020SOU EXTENSION 2 GRANTED
Thursday, April 9, 2020SOU EXTENSION 2 FILED
Thursday, April 9, 2020SOU TEAS EXTENSION RECEIVED
Friday, October 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 9, 2019SOU EXTENSION 1 GRANTED
Wednesday, October 9, 2019SOU EXTENSION 1 FILED
Wednesday, October 9, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, April 9, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 12, 2019PUBLISHED FOR OPPOSITION
Wednesday, January 23, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 9, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, January 7, 2019ASSIGNED TO LIE
Thursday, December 13, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 13, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, December 13, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 13, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, December 13, 2018EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 11, 2018ASSIGNED TO EXAMINER
Thursday, September 6, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

therafuze implants biological materials processed bone namely surgical comprised